Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-16

FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for diazepam from Hikma Pharmaceuticals USA Inc., updating the approval status of this generic product under an abbrevia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)